In other countries
The same active substances on other registers, the same brand first.
- Cutaquig 165 mg/ml, oplossing voor injectieNetherlands · Oplossing voor injectie · Octapharma GmbHSame form
- Cuvitru 200 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Baxalta Innovations GmbHSame form
- Deqsiga 100 mg/ml oplossing voor infusieNetherlands · Oplossing voor infusie · Takeda Manufacturing Austria AGSame form
- Cuvitru 200MG/ML InjectionSaudi Arabia · Baxalta Belgium Manufacturing SASame form
- Cuvitru 200MG/ML InjectionSaudi Arabia · Baxalta Belgium Manufacturing SASame form
- Cuvitru 200MG/ML InjectionSaudi Arabia · Baxalta Belgium Manufacturing SASame form
- DeqsigaEuropean Union · Takeda Manufacturing Austria AGSame substance
- Flebogamma DIF (previously Flebogammadif)European Union · Instituto Grifols S.A.Same substance
- HizentraEuropean Union · CSL Behring GmbHSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence 1.0 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Human normal immunoglobulin
- Strength
- 50 mg/ml
- Dosage form
- infusion, solution
- Route
- intravenous
- Register
- Singapore (HSA)
- Status
- Authorised
- Status in the register
- Registered
- Authorised
- 26 Jun 2012
- Registration
- SIN14178P
- Marketing authorisation holder
- Grifols Asia Pacific Pte. LTD.
- Manufacturer
- Biotest AG, GERMANY
- ATC code
- J06BA02
- Supply
- Prescription Only



